Ads
related to: left ventricular assistive device- Heart Failure Stages
Access Our Heart Failure Guide.
Learn About Heart Failure Stages.
- Heart Failure Treatment
Download Our Free Treatment Guide.
Discover Options for Heart Failure.
- Heart Failure Symptoms
Access a Free Treatment Guide.
Understand Heart Failure Symptoms.
- Living With Heart Failure
Access a Heart Failure Guide.
Learn About Treatment Options.
- Heart Failure Stages
Search results
Results from the WOW.Com Content Network
The HeartAssist5 weighs 92 grams, is made of titanium and plastic, and serves to pump blood from the left ventricle into the aorta. [33] A phase 1 clinical trial is underway (as of August 2009), consisting of patients with coronary artery bypass grafting and patients in end-stage heart failure who have a left ventricular assist device.
Berlin Heart GmbH is a German company that develops, produces and markets ventricular assist devices (VADs). The devices mechanically support the hearts of patients with end-stage heart failure. Berlin Heart's products include the implantable INCOR VAD and the paracorporeal EXCOR VAD. To date, Berlin Heart produces the only device of its kind ...
The HeartMate II is a continuous-flow left ventricular assist device (LVAD) implanted alongside a patient’s native heart with the purpose of pumping for the heart’s left ventricle. It is surgically implanted just below the diaphragm in the abdomen and attached to the aorta, leaving natural circulation in place as it assists in providing ...
Impella is a family of medical devices used for temporary ventricular support in patients with depressed heart function. Some versions of the device can provide left heart support during other forms of mechanical circulatory support including ECMO and Centrimag.
The first Left Ventricular Assist Device (LVAD) system was created by Domingo Liotta at Baylor College of Medicine in Houston in 1962. [92] Another VAD, the Kantrowitz CardioVad, designed by Adrian Kantrowitz, boosts the native heart by taking up over 50% of its function. [93]
In 2000, the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial was conducted. REMATCH was a multi-center study supported by the National Heart, Lung, and Blood Institute to compare long-term implantation of left ventricular assist devices with optimal medical management for patients with end-stage heart failure who require, but do not ...
ReliantHeart, Inc. is a privately held American company headquartered in Houston, Texas that designs, manufactures, and provides remote monitoring capabilities for its left ventricular assist devices (LVAD, or VAD) which are used to assist circulation for failing hearts.
Based on the approval of cardiac contractility modulation devices, the therapy is a treatment option for patients that are at least 18 years old who suffer from heart failure symptoms due to left ventricular systolic dysfunction (LVSD) despite adequate medical treatment. Further clinical research are under way to identify which patient group ...
Ads
related to: left ventricular assistive device